BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS Share Price

Certificat

C5C3Z

DE000CU1CRW3

Market Closed - Euronext Paris 10:00:01 26/04/2024 pm IST
2.957 EUR +6.02% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS
Current month-24.39%
1 month-19.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
26/24/26 2.957 +6.02% 100
25/24/25 2.789 -13.84% 102
24/24/24 3.237 -18.99% 94
23/24/23 3.996 +10.88% 97
22/24/22 3.604 +16.30% 102

Real-time Euronext Paris

Last update April 26, 2024 at 10:00 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
C5C3Z
ISINDE000CU1CRW3
Date issued 15/04/2019
Strike 191.4 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 8.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 21.62
Lowest since issue 2.746

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
221 CHF
Average target price
279.4 CHF
Spread / Average Target
+26.42%
Consensus
  1. Stock Market
  2. Certificates
  3. C5C3Z Certificat